Benzodiazepine Use Is Associated With an Increased Risk of Neurocognitive Impairment in People Living With HIV

TitleBenzodiazepine Use Is Associated With an Increased Risk of Neurocognitive Impairment in People Living With HIV
Publication TypeJournal Article
Year of Publication2019
AuthorsSaloner, R, Grelotti, DJ, Tyree, G, Sundermann, EE, Qing, M, Letendre, S, Heaton, RK, Cherner, M
JournalJournal of Acquired Immune Deficiency Syndromes
Volume82
Start Page475
Date Published12/2019
Abstract

Despite potential for dependence and adverse neurological effects, long-term benzodiazepine (BZD) use is common among people living with HIV (PLWH). As PLWH are at risk for central nervous system dysfunction, we retrospectively examined the association between BZD use and HIV-associated neurocognitive impairment (NCI).